HIF activation by pH-dependent nucleolar sequestration of VHL

Nature Cell Biology

Volumn 6, Issue 7, 2004, Pages 642-647

  Mekhail, Karim ^a   Gunaratnam, Lakshman ^a   Bonicalzi, Marie Eve ^a   Lee, Stephen ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PROTON; VON HIPPEL LINDAU PROTEIN;

ACIDOSIS; ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOLUS; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

ACIDOSIS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL COMPARTMENTATION; CELL HYPOXIA; CELL NUCLEOLUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUMINESCENT PROTEINS; MICE; NUCLEAR PROTEINS; OXIDATION-REDUCTION; OXYGEN; PC12 CELLS; RATS; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

ANIMALIA;

EID: 3242725198     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1144     Document Type: Article

References (30)

1. Semenza, G. L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-1991(2000).
2. Maxwell, P. H. et al . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275 (1999).
3. 2-regulated prolyl hydroxylation. Science 292, 468-472 (2001).
4. Shou, W. et al. Exit from mitosis is triggered by Tem1-dependent release of the protein phosphatase Cdc14 from nucleolar RENT complex. Cell 97, 233-244 (1999).
5. Visintin, R., Hwang, E. S. & Amon, A. Cfi1 prevents premature exit from mitosis by anchoring Cdc14 phosphatase in the nucleolus. Nature 398, 818-823 (1999).
6. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20-26 (1999).
7. Tsai, R. Y. & McKay, R. D. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells, Genes Dev. 16, 2991-3003 (2002).
8. Wagner, P. D. Skeletal muscle angiogenesis. A possible role for hypoxia. Adv. Exp. Med. Biol. 502, 21-38 (2001).
9. Kaelin, W. G., Jr. Molecular basis of the VHL hereditary cancer syndrome. Nature Rev. Cancer 2, 673-682 (2002).
10. Harris, A. L. Hypoxia - a key regulatory factor in tumour growth. Nature Rev. Cancer 2 , 38-47 (2002).
11. Currin, R. T., Gores, G. J., Thurman, R. G. & Lemasters, J. J. Protection by acidotic pH against anoxic cell killing in perfused rat liver: evidence for a pH paradox. Faseb J. 5, 207-210 (1991).
12. Kaku, D. A., Giffard, R. G. & Choi, D. W. Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260, 1516-1518 (1993).
13. Giffard, R. G., Monyer, H., Christine, C. W. & Choi, D. W. Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res. 506, 339-342 (1990).
14. Morimoto, Y., Kemmotsu, O. & Alojado, E. S. Extracellular acidosis delays cell death against glucose-oxygen deprivation in neuroblastoma x glioma hybrid cells. Crit. Care Med. 25, 841-847 (1997).
15. Nielsen, O. B., de Paoli, F. & Overgaard, K. Protective effects of lactic acid on force production in rat skeletal muscle. J. Physiol. 536, 161-166 (2001).
16. Lee, S. et al. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein. Mol. Cell Biol. 19, 1486-1497 (1999).
17. Groulx, I. & Lee, S. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell Biol. 22, 5319-5336 (2002).
18. Kibel, A., Iliopoulos, O., DeCaprio, J. A. & Kaelin, W. G., Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269, 1444-1446 (1995).
19. Corless, C. L., Kilbel, A. S., Iliopoulos, O. & Kaelin, W. G., Jr. Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. Hum. Pathol. 28, 459-464 (1997).
20. Warburg, O. The metabolism of tumors (R. R. Smith, New York, NY, USA, 1931).
21. Warburg, O. On the origin of cancer cells. Science 123, 309-314 (1956).
22. Sutherland, R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240, 177-184 (1988).
23. Iliopoulos, O., Kibel, A., Gray, S. & Kaelin, W. G., Jr. Tumour suppression by the human von Hippel-Lindau gene product. Nature Med. 1, 822-826 (1995).
24. Pause, A. et al. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl Acad. Sci. USA 94, 2156-2161 (1997).
25. Cockman, M. E. et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741 (2000).
26. Bonicalzi, M. E., Groulx, I., de Paulsen, N. & Lee, S. Role of exon 2-encoded beta - domain of the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 276, 1407-1416 (2001).
27. -/-) renal cell carcinoma cells. J. Biol. Chem. 278, 44966-44974 (2003).
28. Chavez, J. C. & LaManna, J. C. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J. Neurosci. 22, 8922-8931 (2002).
29. Sun, Y. et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851 (2003).
30. Bachant, J. B. & Elledge, S. J. Mitotic treasures in the nucleolus. Nature 398, 757-758 (1999).